相关实验视频

Updated: Sep 18, 2025

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

血蛋白质组学和转录组学的综合分析揭示了牛皮的潜在治疗点

Hesong Wang¹, Chenguang Wang², Ruihao Qin¹

¹Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150086, China.

|June 26, 2025

概括

这项研究通过分析全蛋白质组数据来确定牛皮 (PsO) 的新疗法点. 像IFNLR1和IFNGR2这样的关键蛋白质显示出新的牛皮治疗的潜力.

科学领域:

遗传学和免疫学遗传学和免疫学
药理学药理学是指药理学的学科.

背景情况:

牛皮 (PsO) 是一种重要的免疫媒介炎症疾病,具有未满足的治疗需求.
现有治疗PsO及其亚型往往导致复发或不充分的反应,需要新的治疗点.

研究的目的:

进行全蛋白质组门德尔随机化 (MR) 分析,以确定牛皮的潜在治疗点.
探索在牛皮中识别的蛋白质标的药用性和细胞表达模式.

主要方法:

利用全蛋白质组的孟德尔随机化 (MR) 与来自英国生物库的蛋白质定量特征位置 (pQTLs) 数据以及来自FinnGen的牛皮表型数据.
采用单细胞RNA测序,蛋白-蛋白相互作用 (PPI) 分析和分子对接来验证和评估候选标的药用性.

主要成果:

确定了13种与PsO风险相关的蛋白质和10种与PsO亚型相关的蛋白质.
通过 colocalization 分析,IFNLR1,IFNGR2,APOF 和 TDRKH 被强有力的确定为顶级候选人.
与IFN家族相关的IFNLR1和IFNGR2显示出在牛皮病变的T细胞中具有药用性和特异性表达.

结论:

IFNLR1,IFNGR2,APOF和TDRKH是牛皮的有希望的治疗点.
IFNLR1和IFNGR2是新型牛皮治疗方法的特别强有力的候选者.
这些发现提供了有关牛皮病原和潜在治疗策略的新见解.

关键词:

药物目标是药物目标.门德尔的随机化是门德尔的随机化血蛋白质组中的血蛋白质组牛皮是一种牛皮.一个单细胞的单细胞.

更多相关视频

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

相关概念视频

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...